Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C
Year: 2025
Type: article
Source: Vaccine
Institutions: University of Cape Town, Institute of Infectious Disease and Molecular Medicine, National Health Laboratory Service, South African Medical Research Council, University of the Witwatersrand, National Institute for Communicable Diseases, South African Tuberculosis Vaccine Initiative, Wellcome Centre for Infectious Diseases Research in Africa, Centre for the AIDS Programme of Research in South Africa, The Francis Crick Institute
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Carnegie Corporation of New York, Wellcome Trust, Department of Science and Innovation, South Africa, Cancer Research UK, Department for International Development, UK Government, European Commission, National Research Foundation, South African Medical Research Council, Department for International Development, Defence Science Institute, Fondation Botnar, National Treasury, Horizon 2020 Framework Programme, Medical Research Council, Division of Research Capacity Development, European and Developing Countries Clinical Trials Partnership, Wellcome Centre for Infectious Diseases Research in Africa
Awards: G1025664000, G2309718249, G2954250518, Adaptive responses to SARS-CoV-2 variants in the context of hybrid immunity and immune impairment, G5062932458, G5257955758, G5306650735, G603494317, Assessing cross-reactive and pre-existing immunity to SARS-CoV-2 in adolescents., G8578690616, Characterizing the spectrum of TB and Co-infection with HIV - the role of Th22 cells
OpenAlex ID: W4412060281